Association of overweight and obesity with health status, weight management, and exercise behaviors among individuals with type 2 diabetes mellitus or with cardiometabolic risk factors.
Journal Information
Full Title: Risk Manag Healthc Policy
Abbreviation: Risk Manag Healthc Policy
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Health Policy & Services
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure: SHIELD is supported by funding from AstraZeneca LP. Dr Gavin serves on an advisory board for AstraZeneca LP. Dr Rodbard is an advisor to AstraZeneca LP and served on speakers’ bureaus for Abbott, Merck, Novo-Nordisk, Pfizer, sanofi-aventis, and GSK; has served as a consultant for Abbott, Novo-Nordisk, Pfizer, sanofi-aventis, GSK, and Takeda; and has received research grants from Biodel and sanofi-aventis. Dr Fox received support for research and consulting from AstraZeneca LP. Dr Grandy is an employee of AstraZeneca LP."
"Disclosure: SHIELD is supported by funding from AstraZeneca LP. Dr Gavin serves on an advisory board for AstraZeneca LP. Dr Rodbard is an advisor to AstraZeneca LP and served on speakers’ bureaus for Abbott, Merck, Novo-Nordisk, Pfizer, sanofi-aventis, and GSK; has served as a consultant for Abbott, Novo-Nordisk, Pfizer, sanofi-aventis, GSK, and Takeda; and has received research grants from Biodel and sanofi-aventis. Dr Fox received support for research and consulting from AstraZeneca LP. Dr Grandy is an employee of AstraZeneca LP."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025